Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acular LS vs Lotemax for Post-Cataract Surgery Inflammation
NCT00366691Phase 4Completed
- Sponsor
- Medical University of South Carolina
- Start
- Feb 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ketorolac tromethamine, loteprednol etabonate in anterior segment inflammation, sponsored by Medical University of South Carolina. Started Feb 2006; status: completed.
02
Drugs
ketorolac tromethamineloteprednol etabonate
03
Conditions
anterior segment inflammation
Beyond the preview
Go deeper on NCT00366691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00366691.